Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 15, 2026 06:26 ET | Source: Research and Markets

Clinical Trial Agreements Course for CROs, Sponsors and Healthcare Organisations: Key Legal, Regulatory and IP Considerations for the EU and UK Markets (July 2, 2026)

Dublin, May 15, 2026 (GLOBE NEWSWIRE) -- The "Clinical Trial Agreements: Key Legal, Regulatory and IP Considerations for the EU and UK Markets (July 2, 2026)" training has been added to ...
May 11, 2026 11:24 ET | Source: Research and Markets

Gastric Cancer Global Clinical Trials Market Review Report 2026: Region, Country (G7 & E7), Phase, Trial Status, End Points Status and Sponsor Type

Dublin, May 11, 2026 (GLOBE NEWSWIRE) -- The "Gastric Cancer - Global Clinical Trials Review, 2026" has been added to ResearchAndMarkets.com's offering. This comprehensive report presents...
May 11, 2026 11:21 ET | Source: Research and Markets

Chronic Lymphocytic Leukemia (CLL) Global Clinical Trials Market Review Report 2026: Region, Country (G7 & E7), Phase, Trial Status, End Points Status and Sponsor Type

Dublin, May 11, 2026 (GLOBE NEWSWIRE) -- The "Chronic Lymphocytic Leukemia (CLL) - Global Clinical Trials Review, 2026" has been added to ResearchAndMarkets.com's offering. This comprehensive...
May 11, 2026 11:19 ET | Source: Research and Markets

Endometriosis Global Clinical Trials Market Review Report 2026: Region, Country (G7 & E7), Phase, Trial Status, End Points Status and Sponsor Type

Dublin, May 11, 2026 (GLOBE NEWSWIRE) -- The "Endometriosis - Global Clinical Trials Review, 2026" clinical trials has been added to ResearchAndMarkets.com's offering.The clinical trial report...
May 08, 2026 09:51 ET | Source: Research and Markets

Clinical Trial Regulatory Requirements (Online Training Course: Sept 14th-15th, 2026) | Understand Regulatory Expectations, Roles, and Responsibilities

Dublin, May 08, 2026 (GLOBE NEWSWIRE) -- The "Clinical Trial Regulatory Requirements (Sept 14th - Sept 15th, 2026)" training has been added to ResearchAndMarkets.com's offering. Clinical trial...
May 07, 2026 07:30 ET | Source: Annovis Bio Inc.

Annovis CEO to Present on Multi-Protein Model of Alzheimer's Disease at Fierce Biotech Week 2026

MALVERN, Pa., May 07, 2026 (GLOBE NEWSWIRE) -- Annovis Bio, Inc. (NYSE: ANVS) (“Annovis” or the “Company”), a Phase 3 clinical-stage biotechnology company developing the investigational oral...
May 06, 2026 10:34 ET | Source: Research and Markets

Microbiomics in Clinical Trials Training Course (ONLINE EVENT: Sept 14, 2026)

Dublin, May 06, 2026 (GLOBE NEWSWIRE) -- The "Microbiomics in Clinical Trials (Sept 14, 2026)" training has been added to ResearchAndMarkets.com's offering.The microbiome plays an important role in...
May 06, 2026 09:20 ET | Source: Research and Markets

Systemic Lupus Erythematosus - Global Clinical Trials Review 2026, Segmented by Region, Country (G7 & E7), Trial Status, Phase, Sponsor Type, and Endpoint Status

Dublin, May 06, 2026 (GLOBE NEWSWIRE) -- The "Systemic Lupus Erythematosus - Global Clinical Trials Review, 2026" has been added to ResearchAndMarkets.com's offering. The report delivers an...
May 01, 2026 09:40 ET | Source: Research and Markets

Clinical Trials Market Insights and Growth Outlook to 2033 - Shift Towards Patient-Centric and Technology-Driven Trial Models Transforming the Industry

Dublin, May 01, 2026 (GLOBE NEWSWIRE) -- The "Clinical Trials Market Insights, Competitive Landscape, and Market Forecast - 2033" has been added to ResearchAndMarkets.com's offering. The global...
May 01, 2026 07:00 ET | Source: MapLight Therapeutics, Inc.

MapLight Therapeutics Announces Completion of Enrollment in ZEPHYR Phase 2 Trial and Updates Expected Timing of Topline Results

Enrollment completed in ML-007C-MA’s ZEPHYR Phase 2 trial in schizophrenia Last patient visit completed for ML-004’s IRIS Phase 2 trial in autism spectrum disorderTopline results from both Phase 2...